🇺🇸 ADMA Biologics, Inc.
Forum topic · ADMA · Company page: financials, ownership and filings
Join the discussion on ADMA Biologics, Inc.
Loading…
Results announced on 4 November 2026
ADMA Biologics, Inc. announced results on 4 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $141 million (up 5% from a year earlier) and net income of $50 million (up 37% from a year earlier).
Mutual funds: 225 funds hold $828 million
225 mutual funds in 2 countries hold shares of ADMA Biologics, Inc. worth $828 million, about 44.7% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 109 funds added shares and 114 sold; on balance they sold $85 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.